| 查看: 1260 | 回复: 11 | |||
| 【有奖交流】积极回复本帖子,参与交流,就有机会分得作者 wlg001 的 19 个金币 ,回帖就立即获得 1 个金币,每人有 1 次机会 | |||
[交流]
欢迎投稿Frontiers in Bioengineering and Biotechnology影响因子6.064
|
|||
|
SCI期刊:Frontiers in Bioengineering and Biotechnology, 影响因子6.064,审稿速度快!! 欢迎投稿专刊 Special Issue " nanomaterials for drug delivery " ! (链接https://www.frontiersin.org/rese ... s-for-drug-delivery) 论文主题包含下面,但不仅限于下面: In modern society, human beings suffer from various diseases. To treat diseases, numerous medication types have been developed. However, many small molecule drugs have low absorption and substantially adverse effects. Thus, it is necessary to solve these problems through the nanomaterials used as drug carriers. To improve the therapeutic effect of small molecule drugs, it is important to enhance the efficiency of targeted and controlled drug delivery. Various kinds of nanomaterials have been developed recently to investigate their characteristics and applications in drug delivery. The efficiency of drug delivery has been significantly improved by the wide use of lipid-based nanomaterials, inorganic or organic nanoparticle-based nanomaterials, polymer-based nanomaterials, hydrogel-based nanomaterials and biomimetic nanomaterials. During the investigation, the physical, chemical and catalytic property has an important effect on the efficiency of drug delivery. Therefore, it is important to reveal these factors on the efficiency of drug delivery. This Research Topic focuses on the structure, function and mechanisms of nanomaterials in the application of drug delivery, and it is devoted to the dissemination of high-quality original research articles or comprehensive reviews on cutting-edge developments in this interdisciplinary field. All types of manuscripts, such as Original Research, Review, Mini-Review, and Opinions, from fields including polymer chemistry, biochemistry, physical chemistry, pharmaceutics, medicine, and material science, are welcomed in this Research Topic. Preferred themes of this research topic include but are not limited to: • Lipid-based nanomaterials • Inorganic or organic nanoparticles-based nanomaterials • Polymer-based nanomaterials • Hydrogel-based nanomaterials • Biomimetic nanomaterials • Nanotechnology and biotechnology-based nanomaterials • Stimulus-responsive nanomaterials • Nanomaterials effects and nanotoxicity Keywords: Drug delivery, Nanotechnology, Nanomaterials, Nanozymes, Antibacterial, Polymers, Photothermal Therapy, Noble Metal Nanoparticles. |
» 猜你喜欢
309求调剂
已经有8人回复
一志愿南航 335分 | 0856 | GPA 4.07 | 有科研经历
已经有8人回复
求调剂
已经有5人回复
求化学调剂
已经有5人回复
085600,材料与化工321分求调剂
已经有10人回复
0703 化学 求调剂,一志愿山东大学 342 分
已经有5人回复
一志愿南开大学0710生物学359求调剂
已经有3人回复
085600,专业课化工原理,320分求调剂
已经有4人回复
材料与化工272求调剂
已经有16人回复
290求调剂
已经有3人回复
» 抢金币啦!回帖就可以得到:
中国农业科学院农业环境与可持续发展研究所博士后招聘
+1/280
陕西理工大学资源与环境、材料化工方向部分调剂指标-理工兼收
+1/190
天津科技大学生物质功能材料研究团队 硕士招生
+1/90
求助有机化学第二版陆阳申东升主编课件或者电子版书籍
+1/84
南方科技大学王鹏团队诚聘药物化学、化学探针、药物递送博士后
+1/79
国自然面上祈福
+1/71
武汉工程大学化环学院程老师课题组招收化学类学硕、化学工程与环境工程专硕调剂
+2/50
广东唯一石化院校——资源与环境专硕招生
+1/42
天津理工大学国家杰青王铁团队招聘
+1/29
浙江大学光电学院极端光学技术与仪器国家重点实验室诚聘极紫外阿秒方向博士后
+1/13
08工学英一数二290 三个奖学金两个省三 一个省创优秀结项 B区求调剂
+1/9
江西科技师范大学 材料与能源招收调剂研究生
+1/7
南京林业大学化学工程学院柏惺峰课题组招收硕士研究生1名
+1/6
长江师范学院化学化工学院2026年硕士研究生接收调剂的通知
+1/6
NTU招聘生物微机电系统/微流控/3D打印/可穿戴器件方向全奖博士/博士后
+1/6
双非有经验之人求调剂
+1/5
广东医科大学 李雪萌教授团队 招收申请考核制博士(临床检验诊断)
+1/5
福建师范大学国家级人才团队招收2026年博士研究生
+1/4
上海交通大学陈倩栎课题组招收2026年申请-考核博士生1名(能源材料方向)
+1/4
哈尔滨医科大学李老师课题组招收生物信息学方向博士、硕士研究生
+1/4
chenhuanlong
禁虫 (文学泰斗)
★
wlg001(金币+1): 谢谢参与
wlg001(金币+1): 谢谢参与
|
本帖内容被屏蔽 |
7楼2023-05-02 23:29:39
Charles ko
禁虫 (初入文坛)
★
wlg001(金币+1): 谢谢参与
wlg001(金币+1): 谢谢参与
|
本帖内容被屏蔽 |
12楼2023-05-06 15:32:33
简单回复
tzynew2楼
2023-05-02 21:17
回复
wlg001(金币+1): 谢谢参与
o 发自小木虫Android客户端
bjdxyxy3楼
2023-05-02 21:26
回复
wlg001(金币+1): 谢谢参与
。 发自小木虫Android客户端
XG-WUST4楼
2023-05-02 21:55
回复
wlg001(金币+1): 谢谢参与
up 发自小木虫IOS客户端
yuekong5楼
2023-05-02 22:18
回复
nono20096楼
2023-05-02 22:56
回复
wlg001(金币+1): 谢谢参与
·
jiaoxg8楼
2023-05-03 14:46
回复
wlg001(金币+1): 谢谢参与





2023-05-04 09:08
回复
wlg001(金币+1): 谢谢参与
预言的漩涡10楼
2023-05-04 10:55
回复
gter_wang11楼
2023-05-04 13:25
回复
wlg001(金币+1): 谢谢参与














回复此楼